CERC DE FARMACOECONOMIE
Înscrieri se pot trimite pe adresa de email:
adina.turcu@umfcv.ro
Activitatea desfășurată este diseminată prin publicarea de articole, abstracte și participarea la congrese naționale și internaționale:
Articole publicate:
1. Baran-Kooiker A, Kagan A, Gaitova k, Holownia-Voloskova M, Turcu-Stiolica A, Kooiker C, Piniazhko O, Czech M. (2019). Applicability of the Evidem Multi-Criteria Decision Analysis Framework for Orphan Drugs – results from a study in 7 Eurasian countries. Acta Poloniae Pharmaceutica (IF=0.447). 76(3), DOI: 10.32383/appdr/102681
2. Subtirelu MS, Turcu-Stiolica A, Vreju FA, Ciurea PL, Dinescu SC, Barbulescu AL, Neamtu J, Danciulescu RC. Cultural Adaptation and Optimization of the Compliance Questionnaire-Rheumatology (CQR) Through Statistical Methods for Patients with Rheumatic Diseases. BRAIN. Broad Research in Artificial Intelligence and Neuroscience. 10( 3), p. 182-194, sep. 2019. ISSN 2067-3957
3. Pednekar P, Agh T, Melmenas M, Raval A, Bennett B, Borah B, Hutchins D, Manias E, Williams A, Hiligsmann M, Turcu-Stiolica A, Zeber J, Abrahamyan L, Bunz T, Peterson A. (2019). Methods for measuring multiple medication adherence: a systematic review – report of the ISPOR medication adherence and persistence special interest group. Value in Health (IF=5.037). 22(2), 139-156, DOI: 10.1016/j.jval.2018.08.006
4. Subtirelu M, Tucu-Stiolica A, Vreju FA, Neamtu J. (2018). The study on the medical adherence of patients to rheumatoid arthritis treatment. Managament & Marketing Journal. 16(1)
5. Kawalec P, Tesar T, Vostalova L, Draganic P, Manova M, Savova A, Petrova G, Rugaja Z, Mannik A, Sowada C, Stawowczyk E, Harsanyi A, Inotai A,Turcu-Stiolica A, Gulbinovic J, Pilc A. (2017). Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review. Frontiers in Pharmacology (IF=3.845). Vol 8:892, DOI: 10.3389/fphar.2017.0089
6. Kawalec P, Stawowczyk E, Tesar T, Skoupa J, Turcu-Stiolica A, Dimitrova M, Petrova G, Rugaja Z, Mannik A, Harsanyi A, Draganic P. (2017). Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries. Frontiers in Pharmacology (IF=3.845). 8:288. DOI: 10.3389/fphar.2017.00288
7. Turcu-Stiolica A, Taerel AE, Turcu-Stiolica R. (2014). Identifying and measuring compliance and adherence in antidepressants taking. Emerging Markets Queries in Finance and Business, Procedia Economics and Finance. DOI information: 10.1016/S2212-5671(14)00535-8
Participări la congresele ISPOR:
1. Turcu-Stiolica A, Subtirelu MS, Turcu-Stiolica M. Systematic review and meta-analysis of cost-effectiveness of incobotulinumtoxin-a in cervical dystonia. Value in Health. 2020; 23(1):S273-S274 (IF=4.748, Q1)
2. Subtirelu MS, Meca AD, Pisoschi CG, Bogdan M, Nitu FM, Matei M, Turcu-Stiolica A. The economic burden assessment of tuberculosis in Dolj county, Romania: a retrospective analysis. Value in Health. 2020; 23(1):S184 (IF=4.748, Q1)
3. Subtirelu MS, Turcu-Stiolica A, Sintonen H. (nov 2019). Translation and cultural adaptation of 15d quality of life questionnaire from english to romanian language. Value in Health (IF=5.037)
5. Subtirelu M, Turcu-Stiolica A, Vreju F, Turcu-Stiolica R, Bogdan M, Neamtu J. The correlation between mental disorder parameters and medical adherence in patients with rheumatoid arthritis. Oct 2018, Value in Health (IF=5.037). 21, S418
6. Turcu-Stiolica A, Tilden D, Guarnieri C, Subtirelu MS. Comparing outcomes between fixed and flexible treatment intervals with botulinum neurotoxins type a in the management of blepharospasm and cervical dystonia – a cost-effectiveness analysis from the romanian perspective. ISPOR 23rd Annual International Meeting, Baltimore, May 2018, Value in Health (IF=5.037). 21, S207
7. Turcu-Stiolica A, Subtirelu MS. Cost-effectiveness of treating romanian post-stroke patients with upper limb spasticity with incobotulinumtoxin-a against conventional therapy. ISPOR 23rdAnnual International Meeting, Baltimore, May 2018, Value in Health (IF=5.037). 21, S206-207
8. Subtirelu MS, Turcu-Stiolica A, Vreju AF, Neamtu J. Potential risks and benefits for using NSAIDS in the treatment of rheumatoid arthritis. ISPOR 23rd Annual International Meeting, Baltimore, May 2018, Value in Health (IF=5.037). 21, S199
9. Subtirelu MS, Turcu-Stiolica A, Vreju AF, Neamtu J. The post-traumatic stress disorder and medication adherence encountered at patients with rheumatic arthritis. ISPOR 20th Annual European Congress, Glasgow, Scotland, November 2017, Value in Health (IF=5.037)
10. Subtirelu MS, Turcu-Stiolica A, Vreju AF, Neamtu J. Translation and validation of the CQR-19 Romanian patients with rheumatic diseases. ISPOR 22nd Annual International Meeting, Boston, MA, USA, May, 2017, Value in Health (IF=5.037), 20(5):A148
11. Sisu R, Popescu A, Turcu-Stiolica A. Depression assessment in patients diagnosed with Parkinson’s disease for clinical practice. ISPOR 22nd Annual International Meeting, Boston, MA, USA, May, 2017, Value in Health (IF=5.037). 20(5):A299
12. Subtirelu MS, Calina CD, Turcu-Stiolica A. Adherence to biophosphonate therapy in postmenopausal Romanian osteoporotic women with hypertension. ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, Value in Health (IF=5.037)19(3):A235
13. Turcu-Stiolica A, Subtirelu M, Mic OC, Measures Taken By The Romanian Ministry Of Health For Better Access To Anti-Egfr Drugs. ISPOR European Congress 2016, Vienna, Value in Health (IF=5.037). 19 (7): A369
14. Turcu-Stiolica A, S Artene, ME Ciurea, DC Calina, L Ungureanu, A Dricu, Cost-Effectiveness Analysis of Treatment for Recurrent Malignant Glioma in Romania, ISPOR European Congress 2016, Vienna, Value in Health (IF=5.037). 19 (7), A736
15. Mic OC, Turcu-Stiolica A. The outcomes of a pharmaceutical care assistance program in a Romanian pharmacy, ISPOR 7th Asia-Pacific Conference, September 3-6, 2016, Singapore, Value in Health (IF=5.037). 19(7): A868